LAURIE SUND: First of all, just letting you know I'm really passionate about this, because obesity is the second leading cause of preventable illness and death, and 42% of our population has obesity
Based on this finding, all Phase 3 TRIUMPH trials use 2 mg as the universal starting dose, with the first escalation to 4 mg occurring at week 5
Hekmat S, et al
Then visit Dr
Only discovered in 1999, ghrelin has profound regulatory effects on your metabolism, including increasing or decreasing hunger, inhibiting stored fat breakdown, and perhaps most importantly for this article, the release of growth hormone
How Policy Shifts Could Expand Obesity Drug Coverage A major barrier preventing widespread access to GLP-1 medications is the lack of insurance coverage, especially for weight loss